V024-9920 Screening compound: N-(4-{[6-(butan-2-yl)-1-(2-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]amino}cyclohexyl)cyclobutanecarboxamide

V024-9920 Screening compound: N-(4-{[6-(butan-2-yl)-1-(2-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]amino}cyclohexyl)cyclobutanecarboxamide
V024-9920 Screening compound: N-(4-{[6-(butan-2-yl)-1-(2-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]amino}cyclohexyl)cyclobutanecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V024-9920
N-(4-{[6-(butan-2-yl)-1-(2-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]amino}cyclohexyl)cyclobutanecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V024-9920

Molecular Formula

C26H33ClN6O (C26 H33 ClN6 O)

Compound Name

N-(4-{[6-(butan-2-yl)-1-(2-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]amino}cyclohexyl)cyclobutanecarboxamide

IUPAC name

N-(4-{[6-(butan-2-yl)-1-(2-chlorophenyl)-1H-pyrazolo[34-d]pyrimidin-4-yl]amino}cyclohexyl)cyclobutanecarboxamide

SMILES

CCC(C)c1nc(NC(CC2)CCC2NC(C2CCC2)=O)c(cnn2-c(cccc3)c3Cl)c2n1

InChI

InChI=1S/C26H33ClN6O/c1-3-16(2)23-31-24(20-15-28-33(25(20)32-23)22-10-5-4-9-21(22)27)29-18-11-13-19(14-12-18)30-26(34)17-7-6-8-17/h4-5,9-10,15-19H,3,6-8,11-14H2,1-2H3,(H,30,34)(H,29,31,32)/t16-,18?,19?/m0/s1

InChI Key

CWZCPAUWPDTODC-IVMQYODDSA-N

MDL Number (MFCD)

MFCD14254642

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

481.04

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.107

Distribution Coefficient, logD

5.088

Water Solubility, LogSw

-5.46

Polar Surface Area

68.005

Acid Dissociation Constant (pKa)

15.23

Base Dissociation Constant (pKb)

6.04

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

53.80

V024-9920 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

GPCR Targeted Library (31838 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • GPCR
  • Phosphatases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V024-9920 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V024-9920?
Check Price and Availability of V024-9920, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V024-9920 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V024-9920
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V024-9920
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V024-9920 available by request